Sign in or create an account to add this stock to your watchlist.
About CanniMed (TSE:CMED)
CanniMed Therapeutics Inc. operates as a plant biopharmaceutical company that specializes in medical cannabis. The company cultivates and sells pharmaceutical-grade cannabis products in dried herbal and oil forms for Canadian patients. It also offers herbal cannabis and cannabis oil; and vaporizers, consumable vaporizer accessories, and herb mills. In addition, the company offers a plant biotechnology research and product development program that focuses on the production of plant-based materials for pharmaceutical, agricultural, and environmental applications. CanniMed Therapeutics Inc. was founded in 1988 and is based in Saskatoon, Canada. As of March 28, 2018, CanniMed Therapeutics Inc. operates as a subsidiary of Aurora Cannabis Inc.
Industry, Sector and Symbol
Industry N/A
Sub-IndustryCannabis
SectorN/A
SymbolTSE:CMED
CUSIPN/A
Phone+1-306-9751207
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net Margins-28.43%
Return on Equity-5.96%
Return on Assets-4.95%
Miscellaneous
EmployeesN/A
Outstanding Shares24,757,000
CanniMed (TSE:CMED) Frequently Asked Questions
What is CanniMed's stock symbol?
CanniMed trades on the Toronto Stock Exchange (TSX) under the ticker symbol "CMED."
Who are CanniMed's key executives?
CanniMed's management team includes the folowing people:
- Mr. Andre Jerome, CEO & Director
- Mr. John Lewis Knowles BComm., CPA, C.A., CFO, Corp. Sec. & Non-Independent Director (Age 63)
- Mr. Howard Harkness, VP of Marketing & Sales
Has CanniMed been receiving favorable news coverage?
News stories about CMED stock have trended somewhat positive recently, according to Accern Sentiment Analysis. Accern identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. CanniMed earned a daily sentiment score of 0.17 on Accern's scale. They also gave news headlines about the company an impact score of 46.43 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the immediate future.
How do I buy shares of CanniMed?
Shares of CMED and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is CanniMed's stock price today?
One share of CMED stock can currently be purchased for approximately C$27.00.
How big of a company is CanniMed?
CanniMed has a market capitalization of C$954.12 million.
How can I contact CanniMed?
CanniMed's mailing address is 1 Plant Technology Road, Box 19A, RR #5, SASKATOON, SK S7K 3J8, Canada. The company can be reached via phone at +1-306-9751207.
MarketBeat Community Rating for CanniMed (CMED)
MarketBeat's community ratings are surveys of what our community members think about CanniMed and other stocks. Vote "Outperform" if you believe CMED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CMED will underperform the S&P 500 over the long term. You may vote once every thirty days.
CanniMed (TSE:CMED) Analyst Ratings History
| Date | Brokerage | Action | Rating | Price Target | Details |
|---|
(Data available from 5/24/2016 forward)
CanniMed (TSE:CMED) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
(Data available from 1/1/2013 forward)
CanniMed (TSE CMED) Insider Trading and Institutional Ownership History
CanniMed (TSE CMED) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 2/8/2018 | Allan Mclay Fowler | Insider | Sell | 31,777 | C$31.81 | C$1,010,826.37 | | |
| 1/31/2018 | Larry Holbrook | Insider | Sell | 10,000 | C$34.89 | C$348,900.00 | | |
| 10/3/2017 | Larry Holbrook | Insider | Sell | 5,000 | C$10.25 | C$51,250.00 | | |
| 9/18/2017 | Larry Holbrook | Insider | Sell | 1,000 | C$9.41 | C$9,410.00 | | |
| 7/31/2017 | Larry Holbrook | Insider | Sell | 100 | C$10.05 | C$1,005.00 | | |
| 7/13/2017 | Saskworks Venture Fund Inc. | Insider | Buy | 126,500 | C$8.35 | C$1,056,275.00 | | |
| 7/7/2017 | Saskworks Venture Fund Inc. | Insider | Buy | 21,500 | C$8.14 | C$175,010.00 | | |
| 6/28/2017 | Brenton Harold Zettl | Director | Buy | 7,300 | C$7.99 | C$58,327.00 | | |
| 6/27/2017 | Brenton Harold Zettl | Director | Buy | 7,300 | C$7.99 | C$58,327.00 | | |
| 6/15/2017 | Brenton Harold Zettl | Director | Buy | 50,000 | C$7.91 | C$395,500.00 | | |
(Data available from 1/1/2013 forward)
CanniMed (TSE CMED) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Today’s Research Reports on VentriPoint Diagnostics, Cotinga Pharmaceuticals, Knight Therapeutics and CanniMed Therapeutics
finance.yahoo.com - April 30 at 8:27 AM |
| Who Are The Top Investors In CanniMed Therapeutics Inc (TSE:CMED)?
finance.yahoo.com - April 18 at 5:43 PM |
| Why CanniMed Therapeutics Inc’s (TSE:CMED) ROE Of 3.37% Does Not Tell The Whole Story
finance.yahoo.com - April 10 at 5:28 PM |
 | UPDATE 1-CanniMed CEO resigns, Aurora Therapeutics exec tapped interim CEO
www.reuters.com - April 2 at 8:43 AM |
| CanniMed CEO resigns, Aurora Therapeutics exec tapped interim CEO
finance.yahoo.com - April 2 at 8:43 AM |
 | Is Aphria Inc. Still Harbouring U.S. Expansion Ambitions?
www.fool.ca - March 26 at 5:14 PM |
| Today’s Research Reports on Knight Therapeutics, Crescita Therapeutics, CanniMed Therapeutics and Cipher Pharmaceuticals
finance.yahoo.com - March 22 at 8:30 AM |
| CanniMed Therapeutics Inc. Announces First Quarter Results
finance.yahoo.com - March 19 at 8:25 AM |
 | Changes to CanniMed Therapeutics Board Following Share Take ... - Business Wire (press release)
www.businesswire.com - March 17 at 8:30 AM |
| Is CanniMed Therapeutics Inc’s (TSE:CMED) Balance Sheet A Threat To Its Future?
finance.yahoo.com - March 17 at 8:30 AM |
| Pot producer Aurora wins shareholder support for CanniMed purchase - Reuters
www.reuters.com - March 10 at 8:25 AM |
| Pot producer Aurora wins shareholder support for CanniMed purchase
finance.yahoo.com - March 9 at 6:47 PM |
| Aurora Cannabis Announces Success in Bid for CanniMed Therapeutics Through the Take-Up of Shares
finance.yahoo.com - March 9 at 6:47 PM |
 | Aurora Cannabis Shareholders Give the Company the Okay to Acquire CanniMed Therapeutics
www.baystreet.ca - March 8 at 6:38 PM |
| Aurora Cannabis Announces Receipt of Final Regulatory Approval for CanniMed Therapeutics Acquisition and its Intention to Take-Up as soon as Minimum Tender Condition is Met
finance.yahoo.com - February 28 at 6:02 PM |
| Pot producer Aurora gets final regulatory nod for CanniMed purchase
finance.yahoo.com - February 28 at 6:02 PM |
| CanniMed Medical Cannabis Topical Cream Provides Fast-Acting Relief to Patients in Need - Business Wire (press release)
www.businesswire.com - February 28 at 8:20 AM |
| CanniMed Medical Cannabis Topical Cream Provides Fast-Acting Relief to Patients in Need
finance.yahoo.com - February 28 at 8:20 AM |
 | UPDATE--CTT Pharmaceutical Holdings, Inc., (CTTH) Announces Canadian Patent for Orally Administrable Nanonized ... - Nasdaq
www.nasdaq.com - February 22 at 8:24 AM |
 | Allan Mclay Fowler Sells 31,777 Shares of CanniMed Therapeutics Inc (CMED) Stock
www.americanbankingnews.com - February 12 at 9:16 PM |
| Marijuana Stocks: A Performance Review and a Look Ahead
www.fool.ca - February 12 at 9:51 AM |
| Aurora Cannabis Inc. vs. Canopy Growth Corp.: Which Heavyweight Cannabis Stock Is the Best Bet Going Forward?
www.fool.ca - February 3 at 9:41 AM |
| Larry Holbrook Sells 10,000 Shares of CanniMed Therapeutics Inc (CMED) Stock
www.americanbankingnews.com - February 1 at 6:30 PM |
| What Scotts Miracle-Gro Said about Its Cannabis-Focused Business
finance.yahoo.com - January 31 at 9:56 AM |
| CanniMed Therapeutics Inc. Announces 2017 Year End Financials Release Date
finance.yahoo.com - January 27 at 9:40 AM |
| Aurora Cannabis Inc. vs. CanniMed Therapeutics Inc.: I’m Not Surprised
www.fool.ca - January 25 at 3:45 PM |
| Canada's Aurora Cannabis to buy CanniMed for C$1.1 billion
www.reuters.com - January 25 at 3:45 PM |
| PRESS DIGEST- Canada-Jan 25
finance.yahoo.com - January 25 at 9:46 AM |
| CanniMed Therapeutics Announces Continued Discussions with Aurora - Business Wire (press release)
www.businesswire.com - January 24 at 8:08 AM |
| PRESS DIGEST- Canada - Jan 24
finance.yahoo.com - January 24 at 8:08 AM |
| PRESS DIGEST- Canada-Jan 23
finance.yahoo.com - January 23 at 5:24 PM |
| CanniMed Therapeutics Announces Continued Discussions with Aurora
finance.yahoo.com - January 23 at 5:24 PM |
| CanniMed Therapeutics Announces Continuation of Discussions with Aurora
finance.yahoo.com - January 22 at 3:56 PM |
| CANADA STOCKS-TSX retreats as railroad and materials shares weigh
finance.yahoo.com - January 22 at 3:56 PM |
| Canadian cannabis firm Aurora in talks to buy both CanniMed and Newstrike: sources
www.reuters.com - January 19 at 6:28 PM |
| CanniMed Topical Cream – An Innovative New Way to Help Patients - Business Wire (press release)
www.businesswire.com - January 18 at 9:17 AM |
| CanniMed Therapeutics Reminds Shareholders to Vote the GREEN Proxy FOR the Acquisition of Newstrike Resources - Business Wire (press release)
www.businesswire.com - January 18 at 9:17 AM |
| Up Cannabis-parent Newstrike's shareholders approve sale to CanniMed
finance.yahoo.com - January 17 at 5:58 PM |
| CanniMed Therapeutics Inc. Announces Director Resignation
finance.yahoo.com - January 17 at 8:44 AM |
| CanniMed Topical Cream – An Innovative New Way to Help Patients
finance.yahoo.com - January 17 at 8:44 AM |
| CanniMed Therapeutics Reminds Shareholders to Vote the GREEN Proxy FOR the Acquisition of Newstrike Resources
finance.yahoo.com - January 17 at 8:44 AM |
| Shareholders of Aurora Cannabis Inc. Will Get Some Important Answers This Week
www.fool.ca - January 15 at 5:46 PM |
| CanniMed Therapeutics Inc. Launches $725 Million Lawsuit Alleging Multiple Claims of Wrongdoing Related to Aurora Hostile Bid
www.businesswire.com - January 13 at 9:00 AM |
| Leading Independent Proxy Advisor ISS Recommends CanniMed Shareholders Vote “FOR” the Newstrike Acquisition
finance.yahoo.com - January 11 at 5:55 PM |
| CanniMed Therapeutics Inc. and Up Cannabis Inc. (Wholly-Owned Licensed Producer of Newstrike Resources Ltd.) Applaud the Province of Saskatchewan on Legalization Framework
finance.yahoo.com - January 8 at 5:57 PM |
| CanniMed Therapeutics Inc. and Up Cannabis Inc. (Wholly-Owned Licensed Producer of Newstrike Resources Ltd ... - Business Wire (press release)
www.businesswire.com - January 3 at 8:12 AM |
| Canadian regulators ask CanniMed to abandon rights plan against Aurora bid - Reuters
www.reuters.com - December 28 at 5:13 PM |
| Aurora Cannabis opposes CanniMed's bid for Newstrike Resources - Reuters
www.reuters.com - December 19 at 5:46 PM |
| CanniMed Therapeutics Inc.'s Latest Attempt to Stifle the Aurora Cannabis Inc. Takeover Bid - The Motley Fool Canada
www.fool.ca - December 19 at 5:46 PM |
| Ontario regulator to hear Aurora, CanniMed cases on Dec. 20
finance.yahoo.com - December 13 at 5:59 PM |
CanniMed (TSE:CMED) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
CanniMed (TSE CMED) Stock Chart for Thursday, May, 24, 2018
Loading chart…
